S 1813 · 117th Congress 2021โ€“2023, ended

Accelerating Access to Critical Therapies for ALS Act

Latest action · May 25, 2021 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 25, 2021
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Accelerating Access to Critical Therapies for ALS Act

This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions.

The Department of Health and Human Services (HHS) shall award grants to eligible entities to facilitate patients' access to investigational drugs that diagnose or treat ALS. The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other severely debilitating neurodegenerative diseases.

HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases.

The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases.

Cosponsors 63

Members who signed on, in the order they did. Signatures ran from May 25, 2021 to Dec 16, 2021; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-AKLisa MurkowskiOriginalMay 25, 2021
I-MEAngus S. King Jr.Jun 7, 2021
R-ARJohn BoozmanJun 7, 2021
D-NHJeanne ShaheenJun 10, 2021
R-WVShelley Moore CapitoJun 10, 2021
D-CAAlex PadillaJul 28, 2021
D-CADianne FeinsteinJul 28, 2021
D-WVJoe Manchin IIIJul 28, 2021
D-MTJon TesterJul 28, 2021
I-AZKyrsten SinemaJul 28, 2021
D-AZMark KellyJul 28, 2021
D-COMichael F. BennetJul 28, 2021
D-VTPatrick J. LeahyJul 28, 2021
R-NDJohn HoevenAug 9, 2021
R-KSRoger MarshallAug 9, 2021

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateHealth, Education, Labor, and Pensions Committee
Referred May 25, 2021

Actions 2

Everything that happened, newest first.

  1. May 25, 2021Introduced in Senate
  2. May 25, 2021Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 3537Accelerating Access to Critical Therapies for ALS ActIdentical billDec 23, 2021

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to direct the Secretary of Health and Human Services to support research on, and expanded access to, investigational drugs for amyotrophic lateral sclerosis, and for other purposes.
Short Title(s) as Introduced
Accelerating Access to Critical Therapies for ALS Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 25, 2021Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.